Getting serious about biosimilars

1 December 2015 0

As patents on the first generation of monoclonal antibodies begin to expire, the cancer community will need to get to grips with the unique issues involved in ensuring the safety and efficacy of copies of [more]

Asking the value for money questions

1 December 2015 0

Delivering the best possible quality of cancer care to every patient requires getting value for money from scarce resources. BBC journalist Matthew Hill earned himself a Best Cancer Reporter Award for taking a critical look [more]

Are tumour boards defunct?

1 March 2014 0

The complexity of cancer, the risks and benefits associated with alternative treatment options, the care needs of patients, all point to the need for input from specialists in many disciplines. But are regular face-to-face multidisciplinary [more]

UA-77507851-1